---
figid: PMC8072122__fonc-11-660712-g001
figtitle: 'Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular Signaling
  Pathways'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8072122
filename: fonc-11-660712-g001.jpg
figlink: /pmc/articles/PMC8072122/figure/f1/
number: F1
caption: Curcumin modulates cancer progression by regulating multiple signal transduction
  pathways. (I) Akt/PI3K/mTOR signaling pathway. PTEN inhibits the activation of Akt
  by PI3K, mTOR phosphorylates p70S6K1 (S6K1) and 4E-BP1 leading to activation of
  pathways involved in cell growth and survival. Curcumin inhibit the Akt/PI3K/mTOR
  pathway by enhancing the activity of PTEN via decreasing miR-21 and inhibiting the
  activity of PI3K via upregulating miR-192-5p, miR-206, miR-203; (II) MAPK signaling
  pathway. Signaling cascades leading to activation of the MEKs, which lead to activation
  of the ERK1/2, p38, and JNK cascades, and then initiate the gene transcription.
  Curcumin activated p38 MAPK via upregulating miR-378, leading to elevated p21/27,
  cleaved-caspase-3,9 expression, decreased Bcl-2, MMP2/9 expression. (III) Wnt/β-catenin
  pathway. Wnt binds both Frizzled and LRP5/6 receptors to initiate the dissociation
  of the Axin/APC/GSK3β complex. β-catenin phosphorylation and then translocates to
  the nucleus to bind TCF/LEF co-transcription factors, which induces the Wnt-response
  gene transcription. Curcumin inhibits the Wnt/β-catenin pathway by inhibiting lncRNA
  H19, lincROR, miR-130, 21 and upregulating miR-192-5p and miR-33b; (IV) JAK/STAT
  signaling. The pathway is activated by the binding of a ligand and then convey signals
  downstream STATs, whereas STATs are transcription factors that activate gene expression;
  (V) p53 signaling pathway. AKT-induced activation of MDM2, which can inhibit the
  antitumor activity of p53. Curcumin enhances the anti-tumor activity of p53 by inhibiting
  lncRNA H19, miR-1246, miR-19; (VI) NF-kB signaling pathway. Signaling cascade leads
  to the phosphorylation of IkBα resulting in degradation by the proteasome. This
  releases the NF-kB/p65/p50 complex and allows it to translocate to the nucleus for
  gene transcription. AKT, v-akt murine thymoma viral oncogene; PI3K, phosphatidylinositol 3-kinase;
  mTOR, mammalian target of rapamycin; PTEN, phosphatase and tensin homolog; MAPK,
  mitogen-activated protein kinase; MMP, matrix metalloprotinase), ERKs (extracellular
  regulated protein kinases), JNK (c-Jun N-terminal kinase; APC, adenomatous polyposis
  coli; Dvl, Disheveled; GSK3β, glycogen synthase kinase 3β; LRP5/6, low density lipoprotein
  receptor-related protein 5/6; TCF/LEF, T-cell factor/lymphoid enhancer-binding factor;
  JAK/STAT, janus kinase/signal transducers and activators of transcription; MDM2,
  murine double minute 2; NF-κB, nuclear factor kappa B; IKK, IκB kinase; IκBa, IkappaBa.
papertitle: 'Curcumin Regulates Cancer Progression: Focus on ncRNAs and Molecular
  Signaling Pathways.'
reftext: Haijun Wang, et al. Front Oncol. 2021;11:660712.
year: '2021'
doi: 10.3389/fonc.2021.660712
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: curcumin | cancer | ncRNA | miRNA | signaling pathway | review
automl_pathway: 0.9585819
figid_alias: PMC8072122__F1
figtype: Figure
redirect_from: /figures/PMC8072122__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8072122__fonc-11-660712-g001.html
  '@type': Dataset
  description: Curcumin modulates cancer progression by regulating multiple signal
    transduction pathways. (I) Akt/PI3K/mTOR signaling pathway. PTEN inhibits the
    activation of Akt by PI3K, mTOR phosphorylates p70S6K1 (S6K1) and 4E-BP1 leading
    to activation of pathways involved in cell growth and survival. Curcumin inhibit
    the Akt/PI3K/mTOR pathway by enhancing the activity of PTEN via decreasing miR-21
    and inhibiting the activity of PI3K via upregulating miR-192-5p, miR-206, miR-203;
    (II) MAPK signaling pathway. Signaling cascades leading to activation of the MEKs,
    which lead to activation of the ERK1/2, p38, and JNK cascades, and then initiate
    the gene transcription. Curcumin activated p38 MAPK via upregulating miR-378,
    leading to elevated p21/27, cleaved-caspase-3,9 expression, decreased Bcl-2, MMP2/9
    expression. (III) Wnt/β-catenin pathway. Wnt binds both Frizzled and LRP5/6 receptors
    to initiate the dissociation of the Axin/APC/GSK3β complex. β-catenin phosphorylation
    and then translocates to the nucleus to bind TCF/LEF co-transcription factors,
    which induces the Wnt-response gene transcription. Curcumin inhibits the Wnt/β-catenin
    pathway by inhibiting lncRNA H19, lincROR, miR-130, 21 and upregulating miR-192-5p
    and miR-33b; (IV) JAK/STAT signaling. The pathway is activated by the binding
    of a ligand and then convey signals downstream STATs, whereas STATs are transcription
    factors that activate gene expression; (V) p53 signaling pathway. AKT-induced
    activation of MDM2, which can inhibit the antitumor activity of p53. Curcumin
    enhances the anti-tumor activity of p53 by inhibiting lncRNA H19, miR-1246, miR-19;
    (VI) NF-kB signaling pathway. Signaling cascade leads to the phosphorylation of
    IkBα resulting in degradation by the proteasome. This releases the NF-kB/p65/p50
    complex and allows it to translocate to the nucleus for gene transcription. AKT,
    v-akt murine thymoma viral oncogene; PI3K, phosphatidylinositol 3-kinase; mTOR,
    mammalian target of rapamycin; PTEN, phosphatase and tensin homolog; MAPK, mitogen-activated
    protein kinase; MMP, matrix metalloprotinase), ERKs (extracellular regulated protein
    kinases), JNK (c-Jun N-terminal kinase; APC, adenomatous polyposis coli; Dvl,
    Disheveled; GSK3β, glycogen synthase kinase 3β; LRP5/6, low density lipoprotein
    receptor-related protein 5/6; TCF/LEF, T-cell factor/lymphoid enhancer-binding factor;
    JAK/STAT, janus kinase/signal transducers and activators of transcription; MDM2,
    murine double minute 2; NF-κB, nuclear factor kappa B; IKK, IκB kinase; IκBa,
    IkappaBa.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pten
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - cur
  - Cu-3
  - Mtor
  - Tor
  - S6k
  - Thor
  - ap
  - Nplp1
  - ras
  - Ras64B
  - Ras85D
  - bsk
  - lic
  - p38b
  - Nurf-38
  - Ebp
  - AIMP2
  - p38a
  - Hrb87F
  - p38c
  - Raf
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - arm
  - arr
  - Erk7
  - rl
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - fz
  - pan
  - Stat92E
  - hop
  - p53
  - betaTub60D
  - hth
  - dl
  - wash
  - Hrb27C
  - Rpt5
  - DCTN2-p50
  - vi
  - Sh
  - Dif
  - Rel
  - IKKepsilon
  - key
  - IKKbeta
  - PTEN
  - MIR21
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - MTOR
  - RPS6KB1
  - MIR206
  - MIR203A
  - MIR378A
  - EIF4EBP1
  - KRAS
  - HRAS
  - NRAS
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - MAPK14
  - MAPK1
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - H19
  - H1-9P
  - LINC-ROR
  - LRP6
  - LRP5
  - EPHB2
  - MAPK3
  - MIR33B
  - MAP2K1
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - MIR99A
  - HNF4A
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - TP53
  - TP63
  - TP73
  - MIR1246
  - MDM2
  - MIR215
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - NFKB1
  - ITK
  - SLC22A3
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
---
